No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6913561 |
chr6:150340035-150340036 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs376135732 |
chr6:150340049-150340050 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs181135299 |
chr6:150340075-150340076 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs370556772 |
chr6:150340087-150340088 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs545088097 |
chr6:150340102-150340103 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs564873663 |
chr6:150340115-150340116 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs185054600 |
chr6:150340130-150340131 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs540628870 |
chr6:150340131-150340132 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs560822732 |
chr6:150340148-150340149 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs148801810 |
chr6:150340162-150340163 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs112730414 |
chr6:150340180-150340181 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs367629230 |
chr6:150340195-150340196 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs543386635 |
chr6:150340223-150340224 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs563494562 |
chr6:150340226-150340227 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs142441566 |
chr6:150340228-150340229 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs115701203 |
chr6:150340252-150340253 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs189984730 |
chr6:150340255-150340256 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs181620867 |
chr6:150340256-150340257 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs550006110 |
chr6:150340277-150340278 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs528003147 |
chr6:150340306-150340307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs563434342 |
chr6:150340326-150340327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs547826058 |
chr6:150340359-150340360 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs567695719 |
chr6:150340368-150340369 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs536921761 |
chr6:150340378-150340379 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs556634608 |
chr6:150340393-150340394 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs202089145 |
chr6:150340418-150340419 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs570224022 |
chr6:150340465-150340466 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs116203892 |
chr6:150340507-150340508 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs9478362 |
chr6:150340526-150340527 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs571831450 |
chr6:150340527-150340528 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs540591402 |
chr6:150340545-150340546 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs554128768 |
chr6:150340572-150340573 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs34708472 |
chr6:150340584-150340585 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs574122979 |
chr6:150340586-150340587 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs552277052 |
chr6:150340591-150340592 |
Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs377186148 |
chr6:150340606-150340607 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs554040490 |
chr6:150340614-150340615 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs543691737 |
chr6:150340649-150340650 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs563444060 |
chr6:150340674-150340675 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs532285352 |
chr6:150340685-150340686 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs71010878 |
chr6:150340705-150340706 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs67182019 |
chr6:150340706-150340707 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs545700396 |
chr6:150340710-150340711 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs565701470 |
chr6:150340715-150340716 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs186803838 |
chr6:150340729-150340730 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs190898397 |
chr6:150340730-150340731 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs375534150 |
chr6:150340751-150340752 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs73779760 |
chr6:150340755-150340756 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs368656276 |
chr6:150340762-150340763 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs147691948 |
chr6:150340792-150340793 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|